Key result
Junctophilin-2 promotes cardiomyocyte survival by blocking MURF1-mediated Junctin ubiquitination and proteasome-dependent degradation, thereby maintaining cytosolic Ca2+ homeostasis under stress.
Why the study?
It was unknown whether and how junctophilin-2 maintains junctin, a scaffold protein stabilizing RyR2, to prevent cardiomyocyte death under stress.
Junctophilin-2 promotes cardiomyocyte survival under stress by preventing MURF1-mediated degradation of junctin, identifying both as potential therapeutic targets for cardiac protection.
Identifies junctophilin-2/MURF1 as potential cardiomyocyte protection targets; leaves open translation to human heart failure therapy.
Aims Junctophilin-2 is required for the development, maturation and integrity of the t-tubule system and the gating stability of RyR2 in cardiomyocytes. This study investigated whether and how junctophilin-2 maintained junctin, a scaffold protein stabilizing RyR2, to prevent cardiomyocyte death under stress. Methods Cardiomyocytes were exposed to conditions of stress including palmitate, doxorubicin, or hypoxia/re-oxygenation. Adenoviral vectors were employed to manipulate expression of junctophilin-2 and junctin in cardiomyocytes. Molecular/cellular/biochemical analyses were conducted. Results Different conditions of stress decreased junctophilin-2 expression through aberrant autophagy and concomitantly induced a reduction of junctin protein in cardiomyocytes. Over-expression of junctophilin-2 preserved the protein levels of junctin and attenuated cytosolic Ca 2+ and apoptosis in cardiomyocytes under stress. Knockdown of junctophilin-2 reproduced the detrimental phenotypes of stress in cardiomyocytes. Notably, over-expression of junctin prevented cardiomyocyte death under stress whereas knockdown of junctin offset the protective effects conferred by junctophilin-2 over-expression. Mechanistically, junctophilin-2 blocked MURF1-junctin interaction thereby preventing junctin ubiquitination and proteasome-dependent degradation. Mass spectrometry analysis identified multiple ubiquitination sites on the junctin protein and the non-ubiquitinated junctin mutant (K8A/K102A/K107A/K140A) was resistant to degradation. Conclusions This study uncovers an unrecognized role of junctophilin-2 in preventing junctin ubiquitination and degradation in maintaining cytosolic Ca 2+ homeostasis. Both junctophilin-2 and junctin represent two new survival factors of cardiomyocytes and thus, may be new therapeutic targets for cardiac protection.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2022) studied Cardiomyocyte stress and apoptosis. Junctophilin-2 (JPH2) and Junctin (JCN) over-expression or knockdown vs. Control vectors (Ad-HA, Ad-GFP) or vehicle was evaluated on Cardiomyocyte apoptosis and cytosolic Ca2+ levels. Junctophilin-2 promotes cardiomyocyte survival by blocking MURF1-mediated Junctin ubiquitination and proteasome-dependent degradation, thereby maintaining cytosolic Ca2+ homeostasis under stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: